BOSTON SCIENTIFIC CORP - 8-K Filing
Boston Scientific entered into a $2 billion accelerated share repurchase agreement with JPMorgan Chase Bank, receiving approximately 30.4 million shares based on the May 15 closing price of $52.68. The final settlement is expected by June 30, 2026, leaving $3 billion remaining under its $5 billion buyback authorization. This repurchase is projected to add $0.02 accretion to adjusted earnings per share in full year 2026. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $BSX